FMO5 and neurodegenerative disease: For the purpose of targeting this enzyme complex for the therapeutic treatment of neurodegenerative diseases, future efforts will need to focus on the identification of both the detailed mechanisms of NADPH oxidase inhibition and developing more specific inhibitors.